Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.58 |
| ▸ | CYP24A1 | Q07973 | 6/20 | 0.56 |
| ▸ | CYP27A1 | Q02318 | 3/20 | 0.56 |
| ▸ | CYP26A1 | O43174 | 3/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.56 |
| ▸ | METAP1 | P53582 | 3/20 | 0.50 |
| ▸ | DRD2 | P14416 | 3/20 | 0.50 |
| ▸ | HTR2A | P28223 | 2/20 | 0.50 |
| ▸ | HTR2C | P28335 | 2/20 | 0.50 |
| ▸ | HTR2B | P41595 | 2/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.50 |
| ▸ | MPO | P05164 | 1/20 | 0.49 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14286892 | 0.91 | ACHE (0.55) | ACHECYP24A1CYP27A1CYP26A1CYP19A1 | |
| SCHEMBL5237012 | 0.87 | ACHE (0.71) | ACHECYP24A1CYP27A1CYP26A1CYP19A1 | |
| SCHEMBL5237022 | 0.87 | ACHE (0.71) | ACHECYP24A1CYP27A1CYP26A1CYP19A1 | |
| SCHEMBL5237018 | 0.87 | ACHE (0.71) | ACHECYP24A1CYP27A1CYP26A1CYP19A1 | |
| SCHEMBL13039619 | 0.85 | DRD2 (0.60) | ACHECYP24A1CYP27A1CYP26A1CYP19A1 | |
| SCHEMBL4708247 | 0.85 | CYP24A1 (0.56) | CYP24A1CYP27A1CYP26A1CYP19A1DRD2 | |
| SCHEMBL7271049 | 0.84 | CYP24A1 (0.56) | ACHECYP24A1CYP27A1CYP26A1CYP19A1 | |
| SCHEMBL316629 | 0.83 | ACHE (0.76) | ACHECYP19A1METAP1HTR2AHTR2C | |
| SCHEMBL22867686 | 0.83 | CYP24A1 (0.55) | ACHECYP24A1CYP27A1CYP26A1CYP19A1 | |
| SCHEMBL2440274 | 0.83 | CYP24A1 (0.56) | ACHECYP24A1CYP27A1CYP26A1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113518805-B | Photoinitiator | 意大利艾坚蒙树脂有限公司 | 2023-08-08 | — | — | CN | disclosed |
| EP-1963292-B1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2012-02-22 | — | — | EP | disclosed |
| US-7700633-B2 | Organic compounds | NOVARTIS AG (CH) | 2010-04-20 | — | — | US | disclosed |
| US-20080262050-A1 | Organic Compounds | NOVARTIS AG (CH) | 2008-10-23 | — | — | US | disclosed |
| EP-1963292-A2 | ORGANIC COMPOUNDS | Novartis Pharma AG (CH) | 2008-09-03 | — | — | EP | disclosed |
| WO-2007067615-A2 | THIADIAZOLE DERIVATIVES AS ANTIDIABETIC AGENTS | NOVARTIS AG (CH) | 2007-06-14 | — | — | WO | disclosed |
| US-5296508-A | Anticholesterol agents for cardiovascular disorders | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-03-22 | — | — | US | disclosed |
| US-5204373-A | Anticholesterol agents | BRISTOL-MYERS SQUIBB COMPANY (US) | 1993-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080262050-A1 | Organic Compounds | PTPRS, PTPRO, PTPRC | ACHE 1237/4885CYP24A1 3784/4885CYP27A1 948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.